Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Jonathan Chang's Stock Ratings
Leerink Partners Analyst
Jonathan Chang is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/16/2025
Updated: Dec 16, 2025
Overall Average Return
-19.1%
Smart Score
Overall Average Return Percentile
11th
Number of Ratings
135
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/20/2025 | REPL | Buy Now | Replimune Group | $9.55 | 36.13% | $3 → $13 | Upgrade | Market Perform → Outperform | Get Alert | |
| 07/22/2025 | REPL | Buy Now | Replimune Group | $9.55 | -68.59% | $21 → $3 | Downgrade | Outperform → Market Perform | Get Alert | |
| 06/30/2025 | ZLAB | Buy Now | Zai Lab | $17.00 | 341.18% | $73 → $75 | Maintains | Outperform | Get Alert | |
| 02/13/2025 | GMAB | Buy Now | Genmab | $31.35 | -13.88% | → $27 | Upgrade | Market Perform → Outperform | Get Alert | |
| 10/08/2024 | VINC | Buy Now | Vincerx Pharma | $0.01 | 15900% | $4 → $2 | Maintains | Outperform | Get Alert | |
| 04/29/2024 | IMCR | Buy Now | Immunocore Hldgs | $36.21 | 104.36% | → $74 | Initiates | → Outperform | Get Alert | |
| 12/08/2023 | NBTX | Buy Now | Nanobiotix | $23.11 | -52.4% | → $11 | Initiates | → Outperform | Get Alert | |
| 08/04/2023 | NVCR | Buy Now | NovoCure | $12.93 | 294.43% | → $51 | Initiates | → Outperform | Get Alert | |
| 01/10/2023 | KPTI | Buy Now | Karyopharm Therapeutics | $6.33 | -21.01% | $6 → $5 | Maintains | Market Perform | Get Alert | |
| 12/07/2022 | REPL | Buy Now | Replimune Group | $9.55 | 256.02% | $30 → $34 | Maintains | Outperform | Get Alert | |
| 11/30/2022 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | → $6 | Initiates | → Outperform | Get Alert | |
| 11/30/2022 | PNT | Buy Now | POINT Biopharma Global | — | — | → $14 | Initiates | → Outperform | Get Alert | |
| 11/15/2022 | CALA | Buy Now | Calithera Biosciences | $0.00 | 666566.67% | $18 → $2 | Downgrade | Outperform → Market Perform | Get Alert | |
| 11/15/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | $10 → $4 | Maintains | Outperform | Get Alert | |
| 11/10/2022 | GMAB | Buy Now | Genmab | $31.35 | 5.26% | $31 → $33 | Maintains | Market Perform | Get Alert | |
| 11/08/2022 | TCRR | Buy Now | TCR2 Therapeutics | — | — | $3 → $2 | Maintains | Market Perform | Get Alert | |
| 11/04/2022 | KPTI | Buy Now | Karyopharm Therapeutics | $6.33 | -5.21% | $5 → $6 | Maintains | Market Perform | Get Alert | |
| 10/03/2022 | REPL | Buy Now | Replimune Group | $9.55 | 214.14% | $37 → $30 | Maintains | Outperform | Get Alert | |
| 08/22/2022 | BCYC | Buy Now | Bicycle Therapeutics | $7.31 | 583.99% | $48 → $50 | Maintains | Outperform | Get Alert | |
| 08/16/2022 | CALA | Buy Now | Calithera Biosciences | $0.00 | 5999900% | $2 → $18 | Maintains | Outperform | Get Alert | |
| 08/12/2022 | VINC | Buy Now | Vincerx Pharma | $0.01 | 39900% | $6 → $5 | Maintains | Outperform | Get Alert | |
| 08/11/2022 | GMAB | Buy Now | Genmab | $31.35 | -1.12% | $30 → $31 | Maintains | Market Perform | Get Alert | |
| 08/11/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | $13 → $10 | Maintains | Outperform | Get Alert | |
| 08/10/2022 | RVMD | Buy Now | Revolution Medicines | $77.56 | -61.32% | $31 → $30 | Maintains | Outperform | Get Alert | |
| 08/09/2022 | MGNX | Buy Now | Macrogenics | $1.38 | 769.57% | $15 → $12 | Maintains | Outperform | Get Alert | |
| 08/09/2022 | RUBY | Buy Now | Rubius Therapeutics | — | — | $2 → $1 | Maintains | Market Perform | Get Alert | |
| 08/09/2022 | MRSN | Buy Now | Mersana Therapeutics | $27.91 | -49.84% | $13 → $14 | Maintains | Outperform | Get Alert | |
| 08/05/2022 | BCYC | Buy Now | Bicycle Therapeutics | $7.31 | 556.63% | $69 → $48 | Maintains | Outperform | Get Alert | |
| 08/05/2022 | REPL | Buy Now | Replimune Group | $9.55 | 287.43% | $48 → $37 | Maintains | Outperform | Get Alert | |
| 06/07/2022 | VINC | Buy Now | Vincerx Pharma | $0.01 | 47900% | $19 → $6 | Maintains | Outperform | Get Alert | |
| 06/03/2022 | IMTX | Buy Now | Immatics | $10.09 | 157.68% | $25 → $26 | Maintains | Outperform | Get Alert | |
| 05/20/2022 | REPL | Buy Now | Replimune Group | $9.55 | 402.62% | $49 → $48 | Maintains | Outperform | Get Alert | |
| 05/13/2022 | VINC | Buy Now | Vincerx Pharma | $0.01 | 151900% | $20 → $19 | Maintains | Outperform | Get Alert | |
| 05/12/2022 | GMAB | Buy Now | Genmab | $31.35 | -4.31% | $39 → $30 | Maintains | Market Perform | Get Alert | |
| 05/11/2022 | ZLAB | Buy Now | Zai Lab | $17.00 | 458.82% | $101 → $95 | Maintains | Outperform | Get Alert | |
| 05/10/2022 | ATNX | Buy Now | Athenex | — | — | $1 → $3 | Maintains | Market Perform | Get Alert | |
| 05/10/2022 | RUBY | Buy Now | Rubius Therapeutics | — | — | $2 → $3 | Maintains | Market Perform | Get Alert | |
| 05/09/2022 | MRSN | Buy Now | Mersana Therapeutics | $27.91 | -49.84% | $13 → $14 | Maintains | Outperform | Get Alert | |
| 05/09/2022 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $2 → $3 | Maintains | Market Perform | Get Alert | |
| 05/06/2022 | IMGN | Buy Now | Immunogen | — | — | $5 → $4 | Maintains | Market Perform | Get Alert | |
| 05/06/2022 | BCYC | Buy Now | Bicycle Therapeutics | $7.31 | 843.91% | $70 → $69 | Maintains | Outperform | Get Alert | |
| 05/05/2022 | KPTI | Buy Now | Karyopharm Therapeutics | $6.33 | -21.01% | $6 → $5 | Maintains | Market Perform | Get Alert | |
| 05/04/2022 | MGNX | Buy Now | Macrogenics | $1.38 | 986.96% | $23 → $15 | Maintains | Outperform | Get Alert | |
| 04/21/2022 | ZLAB | Buy Now | Zai Lab | $17.00 | 494.12% | $102 → $101 | Maintains | Outperform | Get Alert | |
| 04/11/2022 | RUBY | Buy Now | Rubius Therapeutics | — | — | $5 → $3 | Maintains | Market Perform | Get Alert | |
| 04/04/2022 | CALA | Buy Now | Calithera Biosciences | $0.00 | 666566.67% | $3 → $2 | Maintains | Outperform | Get Alert | |
| 03/30/2022 | VINC | Buy Now | Vincerx Pharma | $0.01 | 159900% | $24 → $20 | Maintains | Outperform | Get Alert | |
| 03/24/2022 | IMTX | Buy Now | Immatics | $10.09 | 147.77% | $32 → $25 | Maintains | Outperform | Get Alert | |
| 03/23/2022 | TCRR | Buy Now | TCR2 Therapeutics | — | — | $7 → $3 | Maintains | Market Perform | Get Alert | |
| 03/17/2022 | ATNX | Buy Now | Athenex | — | — | $2 → $3 | Maintains | Market Perform | Get Alert | |
| 03/15/2022 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $7 → $3 | Maintains | Market Perform | Get Alert | |
| 03/02/2022 | ZLAB | Buy Now | Zai Lab | $17.00 | 500% | $194 → $102 | Maintains | Outperform | Get Alert | |
| 03/02/2022 | KPTI | Buy Now | Karyopharm Therapeutics | $6.33 | -5.21% | $8 → $6 | Maintains | Market Perform | Get Alert | |
| 02/25/2022 | RUBY | Buy Now | Rubius Therapeutics | — | — | $14 → $5 | Maintains | Market Perform | Get Alert | |
| 02/25/2022 | KURA | Buy Now | Kura Oncology | $10.48 | 167.26% | $41 → $28 | Maintains | Outperform | Get Alert | |
| 02/25/2022 | MGNX | Buy Now | Macrogenics | $1.38 | 1566.67% | $40 → $23 | Maintains | Outperform | Get Alert | |
| 02/22/2022 | IMGN | Buy Now | Immunogen | — | — | $7 → $5 | Maintains | Market Perform | Get Alert | |
| 02/18/2022 | MRSN | Buy Now | Mersana Therapeutics | $27.91 | -42.67% | $25 → $16 | Maintains | Outperform | Get Alert | |
| 02/17/2022 | GMAB | Buy Now | Genmab | $31.35 | 24.4% | $42 → $39 | Maintains | Market Perform | Get Alert | |
| 01/20/2022 | CALA | Buy Now | Calithera Biosciences | $0.00 | 999900% | $1 → $3 | Upgrade | Market Perform → Outperform | Get Alert | |
| 01/10/2022 | KPTI | Buy Now | Karyopharm Therapeutics | $6.33 | 26.38% | $6 → $8 | Maintains | Market Perform | Get Alert | |
| 12/17/2021 | BCYC | Buy Now | Bicycle Therapeutics | $7.31 | 857.59% | → $70 | Initiates | → Outperform | Get Alert | |
| 11/11/2021 | HARP | Buy Now | Harpoon Therapeutics | — | — | $25 → $19 | Maintains | Outperform | Get Alert | |
| 11/10/2021 | TCRR | Buy Now | TCR2 Therapeutics | — | — | $8 → $7 | Maintains | Market Perform | Get Alert | |
| 11/10/2021 | ZLAB | Buy Now | Zai Lab | $17.00 | 1041.18% | $200 → $194 | Maintains | Outperform | Get Alert | |
| 11/09/2021 | RUBY | Buy Now | Rubius Therapeutics | — | — | $20 → $14 | Maintains | Market Perform | Get Alert | |
| 11/01/2021 | VINC | Buy Now | Vincerx Pharma | $0.01 | 191900% | → $24 | Initiates | → Outperform | Get Alert | |
| 10/29/2021 | IMGN | Buy Now | Immunogen | — | — | $6 → $5 | Maintains | Market Perform | Get Alert | |
| 10/21/2021 | TCRR | Buy Now | TCR2 Therapeutics | — | — | $18 → $8 | Downgrade | Outperform → Market Perform | Get Alert | |
| 09/13/2021 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $6 → $7 | Maintains | Market Perform | Get Alert | |
| 09/07/2021 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $5 → $6 | Maintains | Market Perform | Get Alert | |
| 08/23/2021 | REPL | Buy Now | Replimune Group | $9.55 | 413.09% | $55 → $49 | Maintains | Outperform | Get Alert | |
| 08/12/2021 | GMAB | Buy Now | Genmab | $31.35 | 33.97% | $37 → $42 | Maintains | Market Perform | Get Alert | |
| 08/12/2021 | RVMD | Buy Now | Revolution Medicines | $77.56 | -51.01% | $46 → $38 | Maintains | Outperform | Get Alert | |
| 08/10/2021 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $6 → $5 | Maintains | Market Perform | Get Alert | |
| 08/09/2021 | REPL | Buy Now | Replimune Group | $9.55 | 475.92% | $56 → $55 | Maintains | Outperform | Get Alert | |
| 08/06/2021 | TCRR | Buy Now | TCR2 Therapeutics | — | — | $34 → $31 | Maintains | Outperform | Get Alert | |
| 08/06/2021 | ATNX | Buy Now | Athenex | — | — | $5 → $4 | Maintains | Market Perform | Get Alert | |
| 08/06/2021 | KPTI | Buy Now | Karyopharm Therapeutics | $6.33 | -5.21% | → $6 | Downgrade | Outperform → Market Perform | Get Alert | |
| 08/06/2021 | HARP | Buy Now | Harpoon Therapeutics | — | — | $29 → $25 | Maintains | Outperform | Get Alert | |
| 08/06/2021 | KURA | Buy Now | Kura Oncology | $10.48 | 291.35% | $40 → $41 | Maintains | Outperform | Get Alert | |
| 08/05/2021 | XNCR | Buy Now | Xencor | $16.55 | 220.24% | $57 → $53 | Maintains | Outperform | Get Alert | |
| 07/15/2021 | IMTX | Buy Now | Immatics | $10.09 | 167.59% | $26 → $27 | Maintains | Outperform | Get Alert | |
| 06/01/2021 | ZLAB | Buy Now | Zai Lab | $17.00 | 1088.24% | $192 → $202 | Maintains | Outperform | Get Alert | |
| 05/11/2021 | RVMD | Buy Now | Revolution Medicines | $77.56 | -40.69% | $55 → $46 | Maintains | Outperform | Get Alert | |
| 05/03/2021 | KPTI | Buy Now | Karyopharm Therapeutics | $6.33 | 136.97% | $22 → $15 | Maintains | Outperform | Get Alert | |
| 04/30/2021 | MGNX | Buy Now | Macrogenics | $1.38 | 2798.55% | $37 → $40 | Maintains | Outperform | Get Alert | |
| 04/14/2021 | ZLAB | Buy Now | Zai Lab | $17.00 | 1029.41% | $183 → $192 | Maintains | Outperform | Get Alert | |
| 03/17/2021 | IMTX | Buy Now | Immatics | $10.09 | 157.68% | $17 → $26 | Maintains | Outperform | Get Alert | |
| 03/15/2021 | RUBY | Buy Now | Rubius Therapeutics | — | — | $4 → $20 | Maintains | Market Perform | Get Alert | |
| 03/11/2021 | TCRR | Buy Now | TCR2 Therapeutics | — | — | $41 → $34 | Maintains | Outperform | Get Alert | |
| 03/11/2021 | HARP | Buy Now | Harpoon Therapeutics | — | — | $31 → $29 | Maintains | Outperform | Get Alert | |
| 03/02/2021 | ATNX | Buy Now | Athenex | — | — | $22 → $5 | Downgrade | Outperform → Market Perform | Get Alert | |
| 02/26/2021 | KURA | Buy Now | Kura Oncology | $10.48 | 281.8% | $42 → $40 | Maintains | Outperform | Get Alert | |
| 02/24/2021 | GMAB | Buy Now | Genmab | $31.35 | 14.83% | $38 → $36 | Maintains | Market Perform | Get Alert | |
| 02/23/2021 | RUBY | Buy Now | Rubius Therapeutics | — | — | $5 → $4 | Maintains | Market Perform | Get Alert | |
| 02/11/2021 | KPTI | Buy Now | Karyopharm Therapeutics | $6.33 | 247.55% | $25 → $22 | Maintains | Outperform | Get Alert | |
| 02/04/2021 | REPL | Buy Now | Replimune Group | $9.55 | 486.39% | $57 → $56 | Maintains | Outperform | Get Alert | |
| 02/03/2021 | ZLAB | Buy Now | Zai Lab | $17.00 | 1011.76% | $107 → $189 | Maintains | Outperform | Get Alert | |
| 01/26/2021 | GMAB | Buy Now | Genmab | $31.35 | 21.21% | $34 → $38 | Maintains | Market Perform | Get Alert | |
| 01/12/2021 | KPTI | Buy Now | Karyopharm Therapeutics | $6.33 | 294.94% | $29 → $25 | Maintains | Outperform | Get Alert | |
| 01/05/2021 | CALA | Buy Now | Calithera Biosciences | $0.00 | 666566.67% | $7 → $2 | Downgrade | Outperform → Market Perform | Get Alert | |
| 01/04/2021 | HARP | Buy Now | Harpoon Therapeutics | — | — | $28 → $31 | Maintains | Outperform | Get Alert | |
| 12/09/2020 | GMAB | Buy Now | Genmab | $31.35 | 8.45% | $36 → $34 | Maintains | Market Perform | Get Alert | |
| 11/09/2020 | MRSN | Buy Now | Mersana Therapeutics | $27.91 | 0.32% | $25 → $28 | Maintains | Outperform | Get Alert | |
| 11/06/2020 | IMGN | Buy Now | Immunogen | — | — | $5 → $6 | Maintains | Market Perform | Get Alert | |
| 11/06/2020 | XNCR | Buy Now | Xencor | $16.55 | 177.95% | $42 → $46 | Maintains | Outperform | Get Alert | |
| 11/05/2020 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $10 → $6 | Maintains | Market Perform | Get Alert | |
| 11/05/2020 | MGNX | Buy Now | Macrogenics | $1.38 | 2581.16% | $38 → $37 | Maintains | Outperform | Get Alert | |
| 11/03/2020 | KPTI | Buy Now | Karyopharm Therapeutics | $6.33 | 342.34% | $30 → $28 | Maintains | Outperform | Get Alert | |
| 10/26/2020 | ATNX | Buy Now | Athenex | — | — | → $22 | Initiates | → Outperform | Get Alert | |
| 10/15/2020 | REPL | Buy Now | Replimune Group | $9.55 | 360.73% | $27 → $44 | Maintains | Outperform | Get Alert | |
| 10/06/2020 | IMGN | Buy Now | Immunogen | — | — | $4 → $5 | Maintains | Market Perform | Get Alert | |
| 09/21/2020 | MGNX | Buy Now | Macrogenics | $1.38 | 2653.62% | $35 → $38 | Maintains | Outperform | Get Alert | |
| 09/10/2020 | ZLAB | Buy Now | Zai Lab | $17.00 | 458.82% | $93 → $95 | Maintains | Outperform | Get Alert | |
| 09/08/2020 | GMAB | Buy Now | Genmab | $31.35 | 11.64% | → $35 | Initiates | → Market Perform | Get Alert | |
| 09/08/2020 | XNCR | Buy Now | Xencor | $16.55 | 135.65% | $42 → $39 | Maintains | Outperform | Get Alert | |
| 08/12/2020 | TCRR | Buy Now | TCR2 Therapeutics | — | — | $26 → $25 | Maintains | Outperform | Get Alert | |
| 08/11/2020 | CALA | Buy Now | Calithera Biosciences | $0.00 | 2333233.33% | $9 → $7 | Maintains | Outperform | Get Alert | |
| 08/10/2020 | RVMD | Buy Now | Revolution Medicines | $77.56 | -49.72% | $40 → $39 | Maintains | Outperform | Get Alert | |
| 08/07/2020 | REPL | Buy Now | Replimune Group | $9.55 | 182.72% | $25 → $27 | Maintains | Outperform | Get Alert | |
| 08/06/2020 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $11 → $10 | Maintains | Market Perform | Get Alert | |
| 08/05/2020 | XNCR | Buy Now | Xencor | $16.55 | 153.78% | $44 → $42 | Maintains | Outperform | Get Alert | |
| 08/04/2020 | KPTI | Buy Now | Karyopharm Therapeutics | $6.33 | 373.93% | $31 → $30 | Maintains | Outperform | Get Alert | |
| 07/27/2020 | IMTX | Buy Now | Immatics | $10.09 | 68.48% | → $17 | Initiates | → Outperform | Get Alert | |
| 05/29/2020 | MGNX | Buy Now | Macrogenics | $1.38 | 1856.52% | $15 → $27 | Maintains | Outperform | Get Alert | |
| 05/27/2020 | MRSN | Buy Now | Mersana Therapeutics | $27.91 | -24.76% | $12 → $21 | Reiterates | → Outperform | Get Alert | |
| 05/06/2020 | MGNX | Buy Now | Macrogenics | $1.38 | 986.96% | $16 → $15 | Reiterates | → Outperform | Get Alert | |
| 05/05/2020 | KPTI | Buy Now | Karyopharm Therapeutics | $6.33 | 358.14% | $30 → $29 | Maintains | Outperform | Get Alert | |
| 05/07/2019 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 05/10/2018 | ARMO | Buy Now | ARMO BioSciences, Inc. - Common Stock | — | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 03/28/2018 | XNCR | Buy Now | Xencor | $16.55 | 117.52% | → $36 | Assumes | Outperform → Outperform | Get Alert | |
| 03/27/2018 | ARMO | Buy Now | ARMO BioSciences, Inc. - Common Stock | — | — | → $50 | Assumes | Market Perform → Outperform | Get Alert | |
| 03/10/2016 | XNCR | Buy Now | Xencor | $16.55 | 8.76% | $22 → $18 | Maintains | Outperform | Get Alert | |
| 03/08/2016 | XNCR | Buy Now | Xencor | $16.55 | 8.76% | $22 → $18 | Maintains | Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved